The confusion about the Food and Drug Administration remains when granting the full approval to the NOVAVAX COVID-19 vaccine deepened during the weekend when the firm of the firm Marty Makary went to social networks to the debatable management of the FDA of the company’s presentation.
In the process, Makary and a spokesman for the Department of Health and Human Services gave the impression of raising the spectrum that in the future, CEQUE vaccine brands would possibly have to generate new knowledge of effectiveness before the publication of annual updates to their vaccines, an obstacle would be illegal.
advertising
“Given that the season lasts only in the number of weeks, when they can approve the vaccines with the studies at the beginning of the season, it would be too past duearray . . . to get the vaccine. It doesn’t make sense,” said Michael Osterholm, director of the Center for Infectious Investigations and Research and Infectious Police.
Understand how science, fitness policy, and medicine shape the global every day and every day
Sharing options
Health and Medicine Frontiers Report
Enterprise
Account
More